TNSN96110A1 - Precurseur medicamenteux de trovafloxacine, procede pour sa preparation et compositions le contenant. - Google Patents

Precurseur medicamenteux de trovafloxacine, procede pour sa preparation et compositions le contenant.

Info

Publication number
TNSN96110A1
TNSN96110A1 TNTNSN96110A TNSN96110A TNSN96110A1 TN SN96110 A1 TNSN96110 A1 TN SN96110A1 TN TNSN96110 A TNTNSN96110 A TN TNSN96110A TN SN96110 A TNSN96110 A TN SN96110A TN SN96110 A1 TNSN96110 A1 TN SN96110A1
Authority
TN
Tunisia
Prior art keywords
trovafloxacin
preparation
compositions containing
same
pii
Prior art date
Application number
TNTNSN96110A
Other languages
English (en)
Inventor
Norris Timothy
John Mcgarry James
John Meldrum Allen Douglas
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN96110A1 publication Critical patent/TNSN96110A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

L'INVENTION CONCERNE UN PRECURSEUR MEDICAMENTEUX DE TROVAFLOXACINE DE FORMULE I : CHOISI COMME POLYMORPHE PII, SON MONOHYDRATE PII.M ET SES FOMES PSEUDOMORPHES PII.PS. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE TELS COMPOSES ET DE TELLES COMPOSITIONS POUR LE TRAITEMENT D'INFECTIONS BACTERIENNES CHEZ DES MAMMIFERES.
TNTNSN96110A 1995-08-29 1996-08-28 Precurseur medicamenteux de trovafloxacine, procede pour sa preparation et compositions le contenant. TNSN96110A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
TNSN96110A1 true TNSN96110A1 (fr) 2005-03-15

Family

ID=21714229

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96110A TNSN96110A1 (fr) 1995-08-29 1996-08-28 Precurseur medicamenteux de trovafloxacine, procede pour sa preparation et compositions le contenant.

Country Status (35)

Country Link
US (1) US6080756A (fr)
EP (1) EP0847400B1 (fr)
JP (1) JPH11509188A (fr)
KR (1) KR100274736B1 (fr)
CN (1) CN1193977A (fr)
AP (1) AP639A (fr)
AR (1) AR004507A1 (fr)
AT (1) ATE208790T1 (fr)
AU (1) AU696414B2 (fr)
BR (1) BR9610283A (fr)
CA (1) CA2230303C (fr)
CO (1) CO4480740A1 (fr)
CZ (1) CZ291524B6 (fr)
DE (1) DE69617027T2 (fr)
DK (1) DK0847400T3 (fr)
DZ (1) DZ2088A1 (fr)
ES (1) ES2164892T3 (fr)
GT (1) GT199600061A (fr)
HR (1) HRP960396A2 (fr)
HU (1) HUP9900226A3 (fr)
IL (1) IL122652A (fr)
MA (1) MA23965A1 (fr)
NO (1) NO309039B1 (fr)
NZ (1) NZ310542A (fr)
OA (1) OA10670A (fr)
PL (1) PL185709B1 (fr)
PT (1) PT847400E (fr)
RU (1) RU2151152C1 (fr)
SK (1) SK283354B6 (fr)
TN (1) TNSN96110A1 (fr)
TR (1) TR199800340T1 (fr)
UA (1) UA48982C2 (fr)
WO (1) WO1997008191A1 (fr)
YU (1) YU48296A (fr)
ZA (1) ZA967281B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) * 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN105510497A (zh) * 2015-11-30 2016-04-20 精晶药业股份有限公司 L-丙氨酰-l-丙氨酸的定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
IL122652A0 (en) 1996-08-16
GT199600061A (es) 1998-01-31
PT847400E (pt) 2002-03-28
JPH11509188A (ja) 1999-08-17
RU2151152C1 (ru) 2000-06-20
US6080756A (en) 2000-06-27
DE69617027T2 (de) 2002-03-21
WO1997008191A1 (fr) 1997-03-06
ZA967281B (en) 1998-03-02
NO980863D0 (no) 1998-02-27
UA48982C2 (uk) 2002-09-16
AP639A (en) 1998-04-14
HUP9900226A2 (hu) 1999-05-28
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
CA2230303C (fr) 2001-07-24
PL325203A1 (en) 1998-07-06
SK283354B6 (sk) 2003-06-03
CA2230303A1 (fr) 1997-03-06
HRP960396A2 (en) 1998-04-30
NO309039B1 (no) 2000-12-04
TR199800340T1 (xx) 1998-06-22
AP9600854A0 (en) 1996-10-31
NO980863L (no) 1998-02-27
CO4480740A1 (es) 1997-07-09
IL122652A (en) 2000-01-31
HUP9900226A3 (en) 1999-11-29
MA23965A1 (fr) 1997-04-01
AU696414B2 (en) 1998-09-10
BR9610283A (pt) 1999-03-16
KR100274736B1 (ko) 2000-12-15
ATE208790T1 (de) 2001-11-15
YU48296A (sh) 1998-12-23
NZ310542A (en) 1999-09-29
MX9801665A (es) 1998-08-30
ES2164892T3 (es) 2002-03-01
KR19990044231A (ko) 1999-06-25
DZ2088A1 (fr) 2002-07-22
CZ55298A3 (cs) 1999-02-17
EP0847400B1 (fr) 2001-11-14
CN1193977A (zh) 1998-09-23
DK0847400T3 (da) 2002-03-25
EP0847400A1 (fr) 1998-06-17
AR004507A1 (es) 1998-12-16
DE69617027D1 (de) 2001-12-20
OA10670A (en) 2000-11-06
CZ291524B6 (cs) 2003-03-12
AU6135196A (en) 1997-03-19

Similar Documents

Publication Publication Date Title
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99169A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98238A1 (fr) Macrolides nouveaux
TNSN00007A1 (fr) Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97055A1 (fr) Derives de 6-phenylpyridyl -2- amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN00104A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN99253A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
TNSN99039A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98154A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant
TNSN99205A1 (fr) Macrolides antibiotiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98035A1 (fr) Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99177A1 (fr) COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1, 2-a] PYRAZINE ET PROCEDE POUR LEUR PREPARATION
TNSN98024A1 (fr) 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN00231A1 (fr) Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant
TNSN99031A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant